Rohto Pharmaceutical Co.,Ltd.

TSE:4527.T

3383 (JPY) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q3
Operating Activities:
Net Income 8,4824,7799,5637,5049,0904,7408,4456,1986,9944,0856,1776,0254,7315,6604,9054,2411,9372,8485,2575,0882,217-1,0723,5543,8773,440-8134,4553,3722,2751,5974,2232,8181,3731,2912,9343,5451,3282,7842,2692,9306487613,6632,6041,9199973,6421,7022,5094,8793,7652,2773,2333,9862,1093,0841,6483,076
Depreciation & Amortization 002,1832,1112,0102,2161,2062,47300000000000000000000000000000000000000001,2141,1501,0911,0061,1831,4791,4761,4321,4801,447
Deferred Income Tax 0000000000000000000000000000000000000000000000000000000000
Stock Based Compensation 0000000000000000000000000000000000000000000000000000000000
Change In Working Capital 000000000000000000000000000000000000000000000000-159-3,821-4,2205,307-71-1,702-3,5943,8104,311-5,195
Accounts Receivables 0000000000000000000000000000000000000000000000000000000000
Change In Inventory 0000000000000000000000000000000000000000000000002,025-676-686-2,1441,562-442-308-1,9951,600-1,126
Change In Accounts Payables 0000000000000000000000000000000000000000000000000000000000
Other Working Capital 000000000000000000000000000000000000000000000000-2,184-3,145-3,5347,451-1,633-1,260-3,2865,8052,711-4,069
Other Non Cash Items -8,482-4,779-9,563-7,504-9,090-4,740-8,445-6,198-6,994-4,085-6,177-6,025-4,731-5,660-4,905-4,241-1,937-2,848-5,257-5,088-2,2171,072-3,554-3,877-3,440813-4,455-3,372-2,275-1,597-4,223-2,818-1,373-1,291-2,934-3,545-1,328-2,784-2,269-2,930-648-761-3,663-2,604-1,919-997-3,642-1,7022,784-270381-4,9692,770-4321,029-4,6981,856-963
Operating Cash Flow 004,3664,2224,0204,4322,4124,94600000000000000000000000000000000000000006,3481,9381,0173,6217,1153,3311,0203,6289,295-1,635
Investing Activities:
Investments In Property Plant And Equipment 000000000000000000000000000000000000000000000000-2,956-1,378-2,747-1,703-1,200-924-1,423-1,268-1,113-2,410
Acquisitions Net 000000000000000000000000000000000000000000000000-29910700000000
Purchases Of Investments 0000000000000000000000000000000000000000000000001,300-1,234-1-357-554-180-31-101-2,000-1
Sales Maturities Of Investments 000000000000000000000000000000000000000000000000-344200000000
Other Investing Activites 000000000000000000000000000000000000000000000000-181-217873-316-187-285-198-60-183-221
Investing Cash Flow 000000000000000000000000000000000000000000000000-1,771-2,724-1,831-2,261-1,698-1,232-1,414-1,372-3,096-2,494
Financing Activities:
Debt Repayment 000000000000000000000000000000000000000000000000-1,430-267-281-291-1,025-286-300-302-175-192
Common Stock Issued 0000000000000000000000000000000000000000000000000000000000
Common Stock Repurchased 0000000000000000000000000000000000000000000000000000000000
Dividends Paid 0000000000000000000000000000000000000000000000000-8230-8230-8230-8230-705
Other Financing Activities 0000000000000000000000000000000000000000000000001,445-2,1061,717-4421,029183277130-4,0815,346
Financing Cash Flow 00000000000000000000000000000000000000000000000015-3,1961,436-1,5564-926-23-995-4,2564,449
Other Information:
Effect Of Forex Changes On Cash 000000000000000000000000000000000000000000000000-10939-31986-4-329-72189-162-490
Net Change In Cash 004,906-1,109389501,540-1,15400000000000000000000000000000000000000004,483-3,942302-1105,417843-4881,4491,780-169
Cash At End Of Period 0081,87776,97178,08077,69177,64176,101000000000000000000000000000000000000000014,0059,52213,46413,16213,2727,8557,0127,5006,0514,271